Conway Kevin John

CIK 2051408 · CHIEF FINANCIAL OFFICER · last filed 2026-02-09

Conway Kevin John is a CHIEF FINANCIAL OFFICER who has filed 8 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for GBIO, was dated Feb 9, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

8

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GBIO CHIEF FINANCIAL OFFICER 0 $5.34 $0 8 2026-02-09

Recent Filings

8 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-09 GBIO Mixed −2,072 $0 EDGAR
2026-02-04 GBIO Mixed +163 -$406 EDGAR
2026-01-16 GBIO Mixed +42 -$96 EDGAR
2025-10-17 GBIO Mixed +40 -$121 EDGAR
2025-07-17 GBIO Mixed +414 -$74 EDGAR
2025-04-17 GBIO Mixed +414 -$64 EDGAR
2025-01-17 GBIO Mixed +383 -$181 EDGAR
2025-01-14 GBIO Grant (A) $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.